Canada

Q1 2021 Dealmaker Roundup

Life sciences gets a COVID booster shot

AUDIOCAST  | 

In this edition of the Dealmaker Roundup, RSM’s Life Sciences Senior Analyst, Adam Lohr, and Jamie Hendershot, Transaction Advisory Director, along with Sean Cunningham, Managing Director at GTCR, share insights about dramatic changes in the industry over the pandemic year.

This Privcap hosted discussion addresses:

  • What's driving the surging IPO market for biotech companies,
  • How clinical trials have continued apace during COVID,
  • Considerations for investing in tool-making companies versus drug developers, and 
  • The need for private equity partners to bring more to the table than just money. 

Related content

Subscribe to our newsletters

Subscribe


HOW CAN WE HELP YOU?

Contact us by phone +1.855.420.8473 or submit your questions, comments or proposal requests


Related Resources


Events

IN-PERSON EVENT

In-Person Events

We proudly sponsor and participate in events that provide innovative ideas and opportunities for you to improve and grow your business.

LIVE WEBCAST

Live Webcasts

We proudly sponsor and participate in events that provide innovative ideas and opportunities for you to improve and grow your business.

LIVE WEBCAST

The Real Economy, Canada: Fall 2021

Join Joe Brusuelas and Alex Kotsopoulos on Oct. 28 as they provide insights on the current state of the Canadian middle market

  • October 28, 2021